Aquestive Therapeutics: president and CEO Daniel Barber sold 25,000 shares

What happened Daniel Barber, president and CEO and a director of Aquestive Therapeutics, sold 25,000 shares in an open-market sale at $4.22 per share on Oct 15, 2026, for $105,600, according to the Form 4 filed Oct 16, 2026.

Key details

• Transaction date and price: Oct 15, 2026 — sale of 25,000 shares at $4.22 per share (transaction table).
• Footnote: the filing states sales occurred from $4.03 to $4.68 per share with a weighted average price of $4.2240; the reporting person will provide the number of shares sold at each price upon request.
• Shares owned after the transaction: not reported in the filing.
• Filing timeliness: Form 4 filed Oct 16, 2026 for the Oct 15, 2026 transaction; the filing does not indicate it was late.

Why it may matter

• This was an open-market sale of shares (not an option exercise or a gift).
• A filing does not show why the insider traded or why the company acted.